Alexander Delp

How many nuts are going to their Doctor to say they want the NVAX

They Can Sell A Combo Sure every year, but they're going to have to protect against new variants. In other words most clowns just gonwith Pfizer or Moderna.

Waiting for FDA approval and they have these vaccines sitting around. How in a goat fucking Kingdom os this gonna move the TICKER

So Billy Goats it was clear on the 12th and this cratered

Gotta be the catalyst for this being at this price now. FDA approval is around the corner. Let me be FRANK that the vaccines are already in the United States per this companies supply chain.

September 12, 2023

Today the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted in favor (13 in favor and 1 against) of a universal recommendation for the use of 2023-2024 (monovalent, XBB containing) COVID-19 vaccines authorized under Emergency Use Authorization (EUA) or approved by Biologics License Application. This vote was later endorsed by the CDC.

“Novavax is pleased that discussions at today’s ACIP meeting showed broad support for COVID vaccination this season via a universal recommendation, and also highlighted the urgent need for a protein-based option. Based on today’s discussion and upon authorization from the FDA, we anticipate that Novavax’s XBB COVID vaccine will be included in the ACIP’s recommendations in accordance with our label,” said John C. Jacobs, President and Chief Executive Officer, Novavax. “Doses of Novavax’s vaccine are already in the U.S. and once authorized, will be the only protein-based non-mRNA vaccine option available for individuals aged 12 and older.”

Novavax presented non-clinical data at the ACIP meeting showing that Novavax’s COVID-19 Vaccine, Adjuvanted (Formula 2023-2024) induced neutralizing antibody responses to a broad range of circulating variants including new data on the FL.1.5.1 (“Fornax”) subvariant as well as robust CD4+ polyfunctional cellular (T-cell) responses against EG.5.1 and XBB.1.16.6, which are becoming more prevalent in the U.S. These data indicate the vaccine can stimulate both arms of the immune system and is capable of inducing a broad response against circulating variants.2

You're so Billy GOAT

Ass up face down don't look back at the charts. Look forward

Billy Goat!! Bill Bill ? Bill Bilky ?

James Whitmer doesn't understand market cap and growth with a model he may be able to afford if his credit inproves. White Trash owns Walmart